C-reactive protein upregulates complement-inhibitory factors in endothelial cells

被引:76
作者
Li, SH [1 ]
Szmitko, PE [1 ]
Weisel, RD [1 ]
Wang, CH [1 ]
Fedak, PWM [1 ]
Li, RK [1 ]
Mickle, DAG [1 ]
Verma, S [1 ]
机构
[1] Univ Toronto, Div Cardiac Surg, Toronto, ON, Canada
关键词
endothelium; atherosclerosis; proteins;
D O I
10.1161/01.CIR.0000117087.27524.0E
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Because complement-mediated vascular injury participates in atherosclerosis and C-reactive protein (CRP) can activate the complement cascade, we sought to determine whether CRP affects the expression of the protective complement-inhibitory factors on the cell surface of endothelial cells (ECs). Methods and Results - Human coronary artery or human saphenous vein ECs were incubated with CRP ( 0 to 100 mug/mL, 0 to 72 hours), and the expression of the complement-inhibitory proteins decay-accelerating factor (DAF), membrane cofactor protein (CD46), and CD59 were measured by flow cytometry. Incubation with CRP resulted in a significant increase in the expression of all 3 proteins. CRP-induced upregulation of DAF required increased steady-state mRNA and de novo protein synthesis. The increased expression of complement-inhibitory proteins was functionally effective, resulting in significant reduction of complement-mediated lysis of antibody-coated human saphenous vein ECs. Conclusions - These observations provide evidence for a possible protective role for CRP in atherogenesis.
引用
收藏
页码:833 / 836
页数:4
相关论文
共 22 条
[1]  
BERMAN S, 1986, J IMMUNOL, V136, P1354
[2]   Complement and atherogenesis - Binding of CRP to degraded, nonoxidized LDL enhances complement activation [J].
Bhakdi, S ;
Torzewski, M ;
Klouche, M ;
Hemmes, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2348-2354
[3]   C-reactive protein: a surrogate risk marker or mediator of atherothrombosis? [J].
Blake, GJ ;
Ridker, PM .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 285 (05) :R1250-R1252
[4]   Vascular smooth muscle cell activation by C-reactive protein [J].
Hattori, Y ;
Matsumura, M ;
Kasai, K .
CARDIOVASCULAR RESEARCH, 2003, 58 (01) :186-195
[5]  
Liszewski MK, 1996, ADV IMMUNOL, V61, P201
[6]   Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition [J].
Mason, JC ;
Yarwood, H ;
Sugars, K ;
Morgan, BP ;
Davies, KA ;
Haskard, DO .
BLOOD, 1999, 94 (05) :1673-1682
[7]   Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury [J].
Mason, JC ;
Ahmed, Z ;
Mankoff, R ;
Lidington, EA ;
Ahmad, S ;
Bhatia, V ;
Kinderlerer, A ;
Randi, AM ;
Haskard, DO .
CIRCULATION RESEARCH, 2002, 91 (08) :696-703
[8]  
Mason JC, 2001, ARTHRITIS RHEUM, V44, P138, DOI 10.1002/1529-0131(200101)44:1<138::AID-ANR18>3.0.CO
[9]  
2-G
[10]   EFFECTS OF TRANSFECTED COMPLEMENT REGULATORY PROTEINS, MCP, DAF, AND MCP/DAF HYBRID, ON COMPLEMENT-MEDIATED SWINE ENDOTHELIAL-CELL LYSIS [J].
MIYAGAWA, S ;
SHIRAKURA, R ;
IWATA, K ;
NAKATA, S ;
MATSUMIYA, G ;
IZUTANI, H ;
MATSUDA, H ;
TERADO, A ;
MATSUMOTO, M ;
NAGASAWA, S ;
SEYA, T .
TRANSPLANTATION, 1994, 58 (07) :834-840